Skip to main content

Blog

Together, let’s advance the research evolution

...

Life is about time and timing when living with Duchenne

...

WATCH: Sevasemten – CANYON Trial Topline Results (Webinar Recording)

...

Support PPMD’s commitment to moving the science further, faster

...

Percheron Announces Termination of Phase 2B Study of Avicursen for Duchenne

...

Your gift to PPMD is a commitment to accelerating progress

...

PPMD Convenes GI, GU, and Swallowing Experts for Two-Day Workshop

...

PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51

...

Edgewise Therapeutics Announces Positive Topline Results from CANYON Phase 2 Trial of Sevasemten in Individuals with Becker

...

Advance the Research Evolution: Introducing PPMD’s Dystrophinopathy Clinical Research Network

...